MARK ANTHONY RUNFOLA, M.D.

Plain English
This study looked at how well patients followed enhanced recovery protocols after emergency surgeries for intestinal issues, specifically after operations like laparotomy. It found that 53.7% of patients were able to start eating and stop IV fluids by the third day after surgery. Factors like being physically frail or having certain health conditions made recovery harder, while better surgical practices helped improve outcomes. Who this helps: This benefits patients recovering from emergency surgeries and their doctors.

Plain English
This research paper studied a new treatment for Parkinson's disease using a drug called 3-Monothiopomalidomide (3MP). The study found that 3MP significantly reduced neuron death and inflammation caused by a toxic protein related to Parkinson's, outperforming another drug, Pomalidomide (POM). Specifically, 3MP preserved important brain cells, reduced harmful protein aggregates, and improved both motor and cognitive functions in rats. Who this helps: This helps patients with Parkinson's disease.

Plain English
This study looked at new chemical structures called aryl-fused bicyclo[3.1.1]heptanes (BCHeps) as replacements for naphthalene, which is commonly found in drugs but can be easily broken down by the body. Researchers created these BCHeps and found that when they were used in a drug called ezutromid, the drug kept its effectiveness while also being more stable and less likely to break down into harmful byproducts. Specifically, these new structures reduced the amount of certain carbon atoms by about 20% and resulted in fewer reactive metabolites. Who this helps: This benefits drug developers and patients by potentially leading to safer and more effective medications.

Plain English
This study looked at creating new versions of the Alzheimer's drug rivastigmine that can also release hydrogen sulfide, a gas that helps protect nerve cells. They found that one of these new compounds, called compound 1, not only blocks an enzyme linked to Alzheimer's but also reduces inflammation and improves cell survival, leading to a longer lifespan in a lab worm model of the disease. This research is important because it could lead to better treatments for Alzheimer's, addressing a growing health crisis as more people are affected by the disease. Who this helps: This helps patients with Alzheimer's and their caregivers by potentially leading to more effective treatments.

Plain English
This study looked at a new drug called TG68 to see how it affects obesity, inflammation, and anxiety in mice fed a high-fat diet. The researchers found that TG68 helped reduce anxiety by around 12%, lowered blood sugar and fat levels, and showed protective effects against brain inflammation and damage. This matters because it suggests TG68 could be a promising treatment for obesity and related brain disorders. Who this helps: This helps patients struggling with obesity and anxiety, as well as those at risk for neurodegenerative diseases.

Plain English
This study looked at children in Sardinia with inflammatory bowel diseases (IBD) like ulcerative colitis (UC) and Crohn's disease (CD) as they transitioned to adult care over a ten-year period. The researchers found that 71 patients had a median age of 12.2 years at diagnosis and that 42% of them were using biologic treatments by the time they transitioned to adult care, compared to just 3% when diagnosed. It also revealed that certain genetic factors are associated with more severe disease in children, leading to a higher risk of needing surgery. Who this helps: This research benefits patients with IBD and their healthcare providers by improving understanding of the disease's progression and treatment options.

Plain English
This study looked at how well hospitals followed enhanced recovery protocols (ERPs) for patients undergoing emergency surgery, specifically for issues like intestinal blockages or tears. Out of 760 patients, the study found that practices like keeping patients warm during surgery and preventing nausea were followed very well (97% and 92% adherence, respectively). However, some important practices, such as monitoring blood pressure and using minimally invasive surgery techniques, were not done well (only 35% and 26% adherence). Overall, 66% of patients were able to eat solid food by the third day after surgery, and the average hospital stay was about 7 days. This research is important because it shows that while some parts of the recovery plan are being followed, there’s still room for improvement, especially in critical areas that could help reduce complications and speed up recovery. Who this helps: Patients undergoing emergency surgery benefit the most from these findings, along with the medical professionals involved in their care.

Plain English
This study looked at a 36-year-old pregnant woman who developed Fournier's gangrene, a serious infection, at 12 weeks of pregnancy. She experienced a high fever and severe anemia, with a large infected area around her genitals. After undergoing surgery and receiving special medication, her condition improved, and she was able to deliver her baby successfully. Who this helps: This benefits pregnant women facing severe infections and their healthcare providers.

Plain English
This study looked at new synthetic compounds that might help repair nerve cells in the brain, specifically by promoting the development of oligodendrocyte precursor cells (OPCs), which are crucial for repairing myelin damage. The researchers found that a compound called TG68 helped these cells mature even in the presence of inflammatory challenges, with results showing a significant increase in OPC differentiation compared to untreated cells. This is important because it suggests a potential new treatment approach for conditions that impair myelin repair, which can lead to serious neurological issues. Who this helps: This benefits patients with central nervous system disorders, such as multiple sclerosis.

Plain English
This study looked at the use of robotic techniques in weight loss surgeries, comparing it to traditional laparoscopic methods, which are the standard. The researchers found that while robotic surgery doesn’t show clear advantages in primary procedures like gastric banding and sleeve gastrectomy, it does result in a longer hospital stay but lower bleeding rates for revisional surgeries. This matters because it indicates that robotic surgery could be a safer option for more complex cases, even if it takes longer to perform. Who this helps: This helps patients undergoing revisional bariatric surgery and their doctors in making informed decisions about surgical options.

Plain English
This study looked at new compounds designed to help protect nerve cells from damage caused by oxidation, which is linked to diseases like retinitis pigmentosa, a major cause of blindness. Researchers created 8-amino-quinoline compounds combined with natural antioxidants and found that these compounds effectively reduced oxidative stress in cell tests, protecting cells from damage. Specifically, they showed promising results in laboratory tests by scavenging harmful molecules and preventing cell death. Who this helps: This benefits patients with retinitis pigmentosa and similar eye disorders.

Plain English
This study looked at laparoscopic sleeve gastrectomy (LSG), a popular weight-loss surgery, to understand how many procedures a surgeon needs to perform before they become skilled. The researchers found that a surgeon needed to complete about 58 surgeries to reach a level of proficiency, with longer surgery times and needing help from experts negatively affecting success rates. This information is important because it can help ensure that patients receive care from skilled surgeons, leading to better outcomes after surgery. Who this helps: This helps patients undergoing weight-loss surgery by ensuring they are treated by experienced surgeons.

Plain English
This study looked at how a new approach called the Enhanced Recovery After Bariatric Surgery (ERABS) program could help improve the care of obese patients undergoing weight-loss surgery. The findings showed that patients in the ERABS program had a shorter average hospital stay of 3.16 days, compared to 4.81 days for those who had standard care, without any increase in complications. This matters because it not only helps patients recover faster but also makes the operating room more efficient. Who this helps: Patients undergoing bariatric surgery.

Plain English
This research paper looks at how diseases that affect the brain and nervous system develop and why finding effective treatments has been so difficult. It points out that imbalances in certain chemical reactions in our bodies can harm our natural defenses and contribute to these progressive diseases. The paper highlights promising natural compounds that might be used to create new treatments, showing that a different approach to drug development—using combinations of therapies—could be the key to tackling these conditions effectively. Who this helps: This helps patients with neurodegenerative diseases and their doctors looking for better treatment options.

Plain English
This study looked at new drugs called thyromimetics, specifically GC-1, IS25, and TG68, to see how well they could stop a harmful protein called transthyretin (TTR) from forming clumps that can lead to health problems like amyloidosis. The researchers used advanced techniques and found that these compounds not only stabilize TTR but also effectively reduce its aggregation. This is important because it suggests a new way to treat conditions linked to TTR, which can impact brain health. Who this helps: This research benefits patients with neurodegenerative diseases related to TTR, such as amyloidosis.

Plain English
This study reported a rare case of a 46-year-old woman who suffered a splenic rupture without any trauma, which was linked to her COVID-19 infection. She arrived at the emergency room with severe symptoms like intense abdominal pain and low blood pressure and needed emergency surgery to remove her spleen. Recognizing that COVID-19 may cause this serious and potentially life-threatening condition is important for timely diagnosis and treatment. Who this helps: This information helps doctors better understand and treat COVID-19 patients with abdominal issues.

Plain English
This research focused on developing new drugs to treat Ewing sarcoma, a type of cancer, by creating compounds that target two specific proteins (PDK1 and AurA). They found that the most effective compound, called compound 12, worked well at very low concentrations and was effective against various cancer types without harming healthy cells. This is important because it shows promise for a new treatment option that could help improve outcomes for Ewing sarcoma patients. Who this helps: Patients with Ewing sarcoma and potentially other cancers.

Plain English
This study looked at a new drug called TG68 that targets a specific thyroid hormone receptor to help treat non-alcoholic fatty liver disease (NAFLD) in mice. After 2 to 3 weeks of treatment, mice showed less fatty buildup in the liver, decreased liver size, and lower levels of harmful liver enzymes and triglycerides in their blood. This matters because it shows that TG68 might effectively improve liver health without causing side effects in other organs. Who this helps: This helps patients with non-alcoholic fatty liver disease.

Plain English
The study looked at a new compound called SG2, which is related to thyroid hormones, to see if it could help treat Alzheimer's disease (AD). Researchers found that SG2 improved brain function and learning in mice engineered to have AD and showed low toxicity in tests. This is important because it offers a potential new direction for developing drugs to help people with Alzheimer's, which currently has limited treatment options. Who this helps: This helps patients with Alzheimer’s disease by potentially providing new treatment options.

Plain English
This study focused on developing new drugs that target a specific thyroid hormone receptor (TRβ) to improve fat metabolism without the harmful side effects linked to the traditional hormone treatment, T3. Researchers found two promising compounds, labeled as 1 and 3, that reduced fat buildup in liver cells and didn't show significant toxicity in early tests. These findings are important because they could lead to safer treatments for obesity and metabolic issues without the negative effects on the heart and bones associated with T3. Who this helps: Patients struggling with obesity and metabolic syndrome.

Plain English
This study looked at a protein called α-synuclein (αS), which is linked to neurodegenerative diseases like Parkinson’s. Researchers found that when αS is modified by a process called N-terminal acetylation, it binds more strongly to lipid membranes but its structure remains mostly the same. This is important because understanding how this protein interacts with membranes can help explain its normal and abnormal behaviors in the brain, which is crucial for developing treatments. Who this helps: This helps patients with neurodegenerative diseases, doctors, and researchers working on potential therapies.

Plain English
This study looked at new synthetic drugs that mimic thyroid hormones, known as thyromimetics, to see how safe they are and whether they might affect unintended areas in the body. Researchers tested these drugs on four different types of human cells and checked for harmful effects and interactions with specific enzymes. They found that the results could help predict which other similar drugs might also be safe or risky. Who this helps: This benefits researchers and drug developers working on thyroid-related treatments.

Plain English
This study looked at two compounds, 3-iodothyronamine (T1AM) and a synthetic version called SG-2, to see how they protect brain cells and improve memory in mice. Researchers found that both compounds boost a process called autophagy, which helps clean up damaged cells, and can improve memory function similarly in mice with Alzheimer's disease, matching T1AM's effectiveness. This is important because it suggests new ways to treat neurodegenerative diseases that affect memory. Who this helps: This benefits patients with Alzheimer's and other neurodegenerative disorders.

Plain English
This study looked at two new drugs, TG68 and IS25, that may help the liver grow new cells without causing harmful side effects often seen with traditional treatments. The researchers found that both drugs increased liver cell growth from 14% to 28% in test subjects, without leading to any noticeable damage to the liver or other organs. This is important because it means these drugs could be safer options for helping patients with liver problems recover or for use in liver transplants. Who this helps: This helps patients with liver diseases and those undergoing liver transplants.

Plain English
This research focused on selective thyroid hormone receptor-beta (TRβ) agonists, which are new types of medications designed to mimic the effects of thyroid hormones in the body. The study found that two promising drugs, Resmetirom and VK2809, are showing good results in lowering lipids (like cholesterol) in patients during clinical trials. Additionally, a new drug, Sob-AM2, has shown significant potential in promoting brain healing in models of multiple sclerosis. Who this helps: This benefits patients with metabolic disorders and neurodegenerative diseases like multiple sclerosis.

Plain English
This study looked at how a bariatric clinic in Italy shifted from in-person appointments to video consultations during the COVID-19 pandemic. Out of 33 patients offered telemedicine, 57.6% participated, and of those, over half reported being very satisfied with the service. The findings highlight that while telemedicine can help healthcare systems under stress, barriers like lack of computer skills can prevent some patients from accessing these services effectively. Who this helps: This benefits patients who seek bariatric care but face challenges in attending in-person appointments.

Plain English
This study looked into a new type of treatment for Alzheimer's disease that uses compounds designed to release hydrogen sulfide, a gas that may help protect brain cells. The researchers created new drug-like molecules by combining a well-known Alzheimer's medication with natural substances found in broccoli and rocket, which are known for their health benefits. They found that these new compounds not only reduced inflammation in brain cells but also showed protective effects against cell damage, highlighting their potential as a treatment for neurodegenerative diseases. Who this helps: This helps patients with Alzheimer's disease and their doctors.

Plain English
This paper looks at new ways to fight glioblastoma multiforme (GBM), the most common and aggressive brain cancer. Researchers found that using treatments that target multiple areas in cancer cells, instead of just one, could lead to better outcomes, especially since current treatments often fail and patients face quick tumor regrowth. By exploring these multi-target therapies, there’s hope for longer survival and improved quality of life for people with GBM. Who this helps: Patients with glioblastoma and their families.

Plain English
This study focused on developing a method to measure fluoxetine, a common antidepressant, in water samples because of concerns about its effects on aquatic life. Researchers created a technique that concentrated fluoxetine from just 6 milliliters of water, achieving an impressive enrichment factor of about 61 and recovering between 83-110% of the drug from various water samples. This method can detect fluoxetine at very low concentrations, with limits as low as 98.9 nanograms per liter, which is critical for monitoring environmental pollution. Who this helps: This benefits environmental scientists and regulators working to protect aquatic ecosystems.

Plain English
This research focused on improving a group of compounds designed to activate a specific receptor in mice, known as mTAAR1, which is linked to important brain and body functions. The study found that several new compounds had a stronger ability to activate mTAAR1 than the original compound SG2, with five of them showing better activity. This is significant because it could lead to new treatments targeting pathways that affect mood and behavior. Who this helps: This helps researchers developing new medications for conditions like depression and anxiety.

Plain English
This study looked at two types of surgical treatments for patients with infected pancreatic necrosis (IPN): one method used only an anterior approach, while the other combined both anterior and posterior approaches. The results showed a significant drop in death rates from 38.1% to 9% and in complications from 57% to 27.2% when the combined approach was used. This matters because it indicates that combining these approaches can lead to better recovery outcomes and potentially save lives in patients dealing with this serious condition. Who this helps: This helps patients with infected pancreatic necrosis and their doctors by providing a more effective surgical option.

Plain English
This study looked at the Advanced Trauma Life Support (ATLS) courses offered in Italy over the past twelve years, which train doctors from various specialties on how to manage serious trauma cases. It found that Italy is now the fourth country in the world for the number of ATLS courses conducted annually, reflecting a significant increase in training opportunities for healthcare providers. This is important because better training helps doctors respond more effectively to trauma cases, improving patients' chances of recovery. Who this helps: This helps patients who experience serious injuries by ensuring that their doctors are better prepared to treat them.

Plain English
This study looked at whether injecting botulinum toxin A into the stomach of obese patients could slow down how quickly their stomachs empty and lead to weight loss. Out of 18 participants, those who received the injections generally felt less hungry and lost some weight, although the weight loss wasn’t large enough to be statistically significant. Understanding how to manage appetite can be important for treating obesity effectively. Who this helps: This helps obese patients looking for new ways to manage their weight.

Plain English
This study looked at how doctors can identify infections in special mesh materials used to repair abdominal hernias using a CT scan. The researchers found that in two patients, the mesh showed a unique change in shape on the scan, indicating infection, which was confirmed during surgery. This finding is important because it can help doctors distinguish between infected and non-infected fluid collections without needing to perform surgery right away. Who this helps: This helps doctors diagnose patients with hernia repairs more accurately, reducing unnecessary surgeries.

Plain English
This research looked at how botulinum toxin can be used to treat digestive tract problems, particularly achalasia—where the food pipe doesn't relax properly—and anal fissures—painful tears in the skin around the anus. The study found that botulinum toxin is the best treatment for achalasia in patients who cannot undergo surgery and is highly effective for anal fissures, potentially becoming the preferred treatment. This matters because it offers a non-surgical option for patients with these painful and challenging conditions. Who this helps: Patients suffering from achalasia and anal fissures.

Plain English
This study looked at how botulinum toxin, injected into the stomach lining of rats, affects the production of stomach acid. Researchers found that rats receiving botulinum toxin produced significantly less stomach acid (657 micromol) compared to those treated with saline (1247 micromol), indicating a major reduction in acidity. This matters because it suggests that botulinum toxin could be used to help manage stomach acid problems, which can lead to discomfort or other health issues. Who this helps: Patients with excessive stomach acid production.

Plain English
This study examined the use of a special mesh, called Goretex Dual Mesh, to close the abdominal wall after surgery for abdominal compartment syndrome (ACS), a serious condition. In five patients treated, the surgery was successful, and there were no complications from the mesh. This is significant because it shows that Goretex Dual Mesh is a safe and effective option for repairing the abdominal wall in these cases. Who this helps: This helps patients recovering from abdominal compartment syndrome.